Share buy-back programs

Covering our commitments

Buy-back programs

Each year at the Annual General Meeting of Shareholders DSM obtains approval for the company to repurchase its own shares.

This approval is necessary as DSM regularly conducts share buy-back programs to cover our commitments to shareholders electing to receive interim and final dividends in the form of ordinary shares and to executives under the terms of their share-based compensation plans.

Each year we also obtain approval to reduce the company's issued capital by cancellation of its shares up to a maximum of the number that is, or will be, bought by the company. On 29 April 2021 DSM announced it had cancelled 6.6m ordinary shares.

Recent programs

May - Jun 2021

DSM repurchased 800,000 shares for a total of €120.3m in accordance with the repurchase program announced on 16 March 2021.

Aug 2020

DSM repurchased 200,000 shares for a total of €26.0m in accordance with the repurchase program announced on 7 August 2020.

Mar 2020

DSM repurchased 1,400,000 shares for a total of €137.8m in accordance with the repurchase program announced on 2 March 20201.

Apr 2019 - Feb 2020

DSM repurchased 9,238,971 shares for a total of €1.01bn in accordance with the repurchase program announced on 14 March 20191, 2

Aug - Oct 2018

DSM repurchased 1,100,000 shares for a total of €98.9m in accordance with the repurchase program announced on 13 August 2018.

Mar - Apr & May - Jun 2018

DSM repurchased 1,600,000 shares for a total of €136.7m in accordance with the repurchase program announced on 19 March 2018.

Aug - Nov 2017

DSM repurchased 1,600,000 shares for a total of €109.3m in accordance with the repurchase program announced on 14 August 2017.

Mar - Jul 2017

DSM repurchased 2,900,000 shares for a total of €187.2m in accordance with the repurchase program announced on 13 March 2017. 

Nov - Dec 2016

DSM repurchased 1,700,000 shares for a total of €96.0m in accordance with the repurchase program announced on 4 November 2016.

Feb - Jul 2016

DSM repurchased 3,500,000 shares for a total of €176.8m in accordance with the repurchase program announced on 22 February 2016.

1) Given Covid-19 and the acquisition of Erber Group, DSM canceled the remainder of the €1 billion share buy-back program in June 2020 having repurchased 6,638,971 shares during 2019 (5.4m shares/€600m) and January - February 2020 for a total of €745 million.

2) On 29 April 2021 DSM announced that it has cancelled 6.6m ordinary shares, thereby concluding the reduction in share capital following the share buyback program executed in the period 1 April 2019 to February 2020. 6,638,971 ordinary shares held in treasury since the execution of the share buyback program have been cancelled. The total number of issued shares is therefore reduced to 218,826,029 (previously 225,465,000), consisting of 174,786,029 ordinary shares and 44,040,000 cumulative preference shares A. 

Statement pursuant to art. 5:25a of the Dutch Financial Supervision Act

DSM declares that the Netherlands is its "Home Member State", as required by article 5:25a (2) of the Dutch Financial Supervision Act. This article obliges all listed companies to publicly announce which country is their "home member state" (as referred to in article 5:25a(1) sub c of the Dutch Financial Supervision Act) for purposes of regulation of their disclosure obligations under the EU Transparency Directive. Pursuant to section 5:25a of the Dutch Financial Supervision Act, Royal DSM has notified the Dutch Authority for the Financial Markets (AFM).

Read more